Immunogenicity, Safety, and Clinical Effectiveness After 2 Doses of BNT162b2 Vaccine Among Pediatric Kidney Transplant Recipients Versus Healthy Volunteers: A Prospective Nonrandomized Study

Transplantation. 2023 Mar 1;107(3):e86-e87. doi: 10.1097/TP.0000000000004498. Epub 2023 Jan 9.

Affiliations

¹ Hospital do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil.
² Municipal Health Secretariat, Ipaussu, São Paulo, Brazil.

No abstract available

Publication types

Clinical Trial

MeSH terms

Antibodies, Viral
BNT162 Vaccine*
Child
Humans
Kidney Transplantation*
Prospective Studies
Transplant Recipients
Treatment Outcome

Substances

BNT162 Vaccine
Antibodies, Viral